New drug interaction study launches for polycystic kidney disease treatment
NCT ID NCT07181265
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 27 times
Summary
This study tests how a new drug called JMKX003142 interacts with two other medicines (amiodarone for heart rhythm and febuxostat for gout) in 48 healthy Chinese adults. It aims to understand how the body processes these drugs together, which will help guide future dosing for people with autosomal dominant polycystic kidney disease. Participants take the drugs in three separate periods and have blood samples taken to measure drug levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.